DNAJA4

DNAJA4 is an Hsp40/DnaJ-family co-chaperone that couples protein quality control to lipid metabolism, cytoprotective stress responses, and the regulation of tumor cell behavior (PMID:16950652, PMID:37875476). As a sterol-responsive gene transcriptionally controlled by SREBP2, DNAJA4 promotes cholesterol biosynthesis by acting on HMG-CoA reductase post-transcriptionally, raising its activity and protein content without altering its mRNA, consistent with a co-translational chaperone effect on the rate-limiting biosynthetic enzyme (PMID:16950652). A recurring theme across its functions is the channeling of client proteins toward proteasomal degradation: in nasopharyngeal carcinoma DNAJA4 recruits the proteasome subunit PSMD2 to drive ubiquitin-proteasome-mediated turnover of MYH9, thereby suppressing epithelial-mesenchymal transition and metastasis (PMID:37875476). In keratinocytes responding to hyperthermic stress, DNAJA4 acts as a negative regulator of NF-κB signaling, restraining TNF-α and IL-1β transcription, and shapes F-actin/RhoA/ROCK1 cytoskeletal dynamics while sitting upstream of cytoprotective Clusterin and ERK signaling (PMID:29807809, PMID:32925288, PMID:32277496). DNAJA4 also functions downstream of a miR-199a/ApoE regulatory axis, supporting ApoE expression in melanoma and vascular smooth muscle cells (PMID:23142051, PMID:26720342). Functional divergence from other DNAJA members is evident, as human DNAJA4 fails to complement loss of yeast YDJ1 under stress, unlike DNAJA1 and DNAJA2 (PMID:32149145). In viral contexts DNAJA4 binds iridovirus PCNA to promote viral DNA replication (PMID:36672799) and promotes proteasomal degradation of hepatitis B virus HBx (PMID:39883729).

1. 2006 Medium

   Established DNAJA4 as a sterol-responsive chaperone that promotes cholesterol biosynthesis, answering whether it has a metabolic function rather than a generic folding role.

   Evidence Subtractive hybridization, dominant-negative SREBP2 adenovirus, and [14C]-acetate cholesterol synthesis assay in adipocytes and COS cells

   PMID:16950652

   Open questions at the time

   • No direct demonstration of physical chaperone-client interaction with HMG-CoA reductase
   • Co-translational mechanism inferred from protein/activity increase without mRNA change, not directly visualized
   • No structural or domain-level analysis
2. 2012 Medium

   Placed DNAJA4 in a miRNA-controlled pro-metastatic circuit by showing convergent miR-1908/miR-199a targeting suppresses DNAJA4 and its downstream effector ApoE.

   Evidence In vivo metastasis selection with miRNA overexpression/inhibition, LNA silencing, and invasion/angiogenesis assays in melanoma

   PMID:23142051

   Open questions at the time

   • DNAJA4's ApoE regulation inferred from miRNA context rather than direct DNAJA4 gain-of-function
   • Mechanism linking DNAJA4 to ApoE expression not defined
   • Does not address chaperone activity
3. 2015 Medium

   Confirmed DNAJA4 as a downstream effector of the miR-199a/ApoE axis in a second cell type, generalizing its role in regulating ApoE.

   Evidence Atherosclerosis macroarray, NPR-C and Egr-1 knockdown, miR199a overexpression, and recombinant ApoE rescue in vascular smooth muscle cells

   PMID:26720342

   Open questions at the time

   • Molecular mechanism by which DNAJA4 supports ApoE expression remains undefined
   • No direct DNAJA4-ApoE interaction shown
   • Effect is correlative within a signaling cascade
4. 2018 Medium

   Identified DNAJA4 as a negative regulator of NF-κB signaling in the hyperthermic stress response, defining a cytoprotective immunomodulatory role.

   Evidence CRISPR/Cas9 knockout, NF-κB inhibitor rescue, RT-qPCR and survival assays in HaCaT keratinocytes and ex vivo tissue

   PMID:29807809

   Open questions at the time

   • Direct molecular target linking DNAJA4 to NF-κB not identified
   • Single lab without reciprocal rescue by DNAJA4 re-expression
   • Mechanism of NF-κB suppression unknown
5. 2020 Medium

   Extended DNAJA4's keratinocyte stress role to cytoskeletal and pro-survival signaling, placing it upstream of RhoA/ROCK1, F-actin dynamics, and Clusterin/ERK protective pathways.

   Evidence CRISPR/Cas9 knockout with immunofluorescence, RNAi of CLU, pharmacological ERK inhibition, and multiple readouts in HaCaT cells

   PMID:32277496 PMID:32925288

   Open questions at the time

   • No pharmacological or rescue validation of RhoA/ROCK1 pathway specificity
   • Whether cytoskeletal and Clusterin/ERK effects are direct chaperone functions is unresolved
   • Connection between these pathways and NF-κB regulation not integrated
6. 2020 Medium

   Demonstrated functional divergence of DNAJA4 from other DNAJA members, showing it cannot substitute for yeast YDJ1 and even interferes with the stress response.

   Evidence Yeast ydj1Δ complementation with doxorubicin, cisplatin, and heat shock survival assays

   PMID:32149145

   Open questions at the time

   • Structural basis of functional divergence not defined
   • Native human clients of DNAJA4 not identified by this assay
   • Negative result does not rule out species-specific chaperone activity
7. 2022 Medium

   Revealed a direct physical partnership with iridovirus PCNA, defining a role for DNAJA4 in supporting viral DNA replication and localizing it to the cytoplasm.

   Evidence Co-IP, GST-pulldown, co-immunofluorescence, overexpression/siRNA viral replication assays in carp epithelial cells (fish ortholog, 68% homology to human)

   PMID:36672799

   Open questions at the time

   • Whether human DNAJA4 binds PCNA orthologs is untested
   • Chaperone activity toward PCNA not biochemically resolved
   • Study uses a fish ortholog
8. 2023 Medium

   Defined the mechanism of DNAJA4's metastasis suppression as PSMD2-dependent proteasomal degradation of MYH9, providing the clearest client/degradation pathway in the corpus.

   Evidence Co-IP, overexpression/knockdown, in vitro migration/invasion, in vivo metastasis models, and MYH9 rescue in nasopharyngeal carcinoma

   PMID:37875476

   Open questions at the time

   • Whether DNAJA4 acts as a classical Hsp40 in this context is not biochemically established
   • Generality beyond NPC unknown
   • Direct ubiquitin ligase partner not identified
9. 2025 Low

   Implicated DNAJA4 in antiviral restriction of HBV by promoting ubiquitin-independent proteasomal degradation of HBx, complementing its proteasome-directed activity seen with MYH9.

   Evidence DNAJA4 overexpression with HBx stability Western blots and HBV replication assays, within an MSX1-focused study

   PMID:39883729

   Open questions at the time

   • DNAJA4's role is a secondary finding with limited direct mechanistic detail
   • Direct DNAJA4-HBx interaction not shown
   • Ubiquitin-independent degradation mechanism not defined

• The biochemical basis of DNAJA4 chaperone activity and the identity of its native human client proteins across these diverse pathways remain undefined.
• No structural model or domain-function mapping for human DNAJA4
• No direct demonstration of Hsp70-coupled chaperone cycle or J-domain function
• Unclear whether metabolic, cytoprotective, degradation, and viral roles share a common chaperone mechanism